COMMUNIQUÉS West-GlobeNewswire

USA Peptides: Kylo Peptides Partners With Freedom Diagnostics for Independent Verification of Research Peptides
22/10/2026
Kylo Peptides Announces Partnership With Freedom Diagnostics Sheridan, Wyoming, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ], a research peptide supplier for laboratory research, today [...]
NurExone Demonstrates Scalable Exosome Production, Supporting Its Modular Manufacturing Strategy and Commercial Growth
22/10/2026
Successful parallel production process maintains consistency while doubling exosome yield without increasing manufacturing time TORONTO and HAIFA, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: [...]
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
22/10/2026
Company leadership, leading cardiologists and trial investigators to discuss unmet patient needs, BACKBEAT and Virtue pivotal trials, and upcoming milestones; in person in New York City and via live webcast NEW HOPE, Pa [...]
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
22/10/2026
Clears Pathway for Execution of Future R&D Milestone Events such as the Phase 1b, FIH Study for PRP in up to 50 Advanced Cancer Patients with Solid Tumors, First Quarter, 2027 MELBOURNE, Australia, Oct. 22, 2026 ( [...]
Eupraxia Pharmaceuticals to Participate at Upcoming Conferences and Host a Virtual Analyst Day
22/10/2026
VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
22/10/2026
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter [...]
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
22/10/2026
- MOU relates to a potential clinical trial in South Korea, Alpha DaRT’s first, at Samsung Medical Center (SMC) in Seoul, ranked fifth in the world and number one in Korea in oncology - - In Korea, only about one in [...]
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026
BURLINGTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report [...]
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
22/10/2026
Company to host conference call on November 5, 2026, at 4:30 p.m. ET MOUNTAIN VIEW, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company [...]
ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update
22/10/2026
WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today [...]
BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness
22/10/2026
BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine. New York, Oct. 22, [...]
Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment
22/10/2026
Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation Discussion features Sanjeev Luther, President and Chief [...]
SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
22/10/2026
TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage [...]
New Study Finds Pycnogenol® Improves Quality of Life and Symptoms Associated with Osteopenia and Osteoporosis in Post-Menopausal Women
22/10/2026
Vitality, physical comfort and markers of bone resorption improved among participants taking Pycnogenol® Key Takeaways Pycnogenol ® , a natural extract from French maritime pine bark, was studied as a dietary supplement [...]
Promaxo Announces Closing of Series C Financing and $100M Credit Facility
22/10/2026
The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings OAKLAND, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Promaxo today announced the initial close of its Series C [...]
FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
22/10/2026
Menopause and pharmacy experts join FEM’s mission to bring greater scientific rigor and evidence-led education to midlife women’s health RUEIL-MALMAISON, France, Oct. 22, 2026 (GLOBE NEWSWIRE) -- FEM By UPSA , a global [...]
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
22/10/2026
Data from ongoing study supports the potential clinical utility of whole-genome sequencing-based Precise MRD™ to identify recurrence risk and detect disease earlier following surgery SALT LAKE CITY, Oct. 22, 2026 (GLOBE [...]
Beacon Biosignals Acquires Snap Diagnostics, Paving the Way for EEG-Enabled Home Sleep Testing in Every Care Setting
22/10/2026
Acquisition more than doubles Beacon’s patient reach, creating a national channel to bring EEG-enabled home sleep testing to primary care, telehealth, psychiatry, and other specialty providers starting in 2027 BOSTON, [...]
Claritas and Qubiotech join forces to build an independent challenger in quantitative PET — from whole body to brain
22/10/2026
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd., a subsidiary of Claritas HealthTech Ltd, today announced that the Claritas group has signed heads of terms to acquire a majority stake in [...]

Pages